InnoVein develops a medical device designed to offer implants for valve replacement in the femoral vein.
InnoVein has raised $2.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
InnoVein's investors include National Science Foundation, Y Combinator, MassChallenge, Creative Destruction Lab (CDL), Zoic Capital.
InnoVein is headquartered in San Carlos, United States.
InnoVein develops a medical device designed to offer implants for valve replacement in the femoral vein.
InnoVein is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InnoVein — Funding & Investors." VCBacked, February 6, 2023, https://www.vcbacked.co/company/innovein. Accessed July 20, 2026.
VCBacked. (2023). InnoVein — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/innovein
{{cite web |title=InnoVein — Funding & Investors |url=https://www.vcbacked.co/company/innovein |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated